The WACC of Innocan Pharma Corp (INNO.CN) is 6.7%.
| Range | Selected | |
| Cost of equity | 5.40% - 8.00% | 6.70% |
| Tax rate | 25.90% - 26.50% | 26.20% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 5.4% - 8.0% | 6.7% |
| Category | Low | High |
| Long-term bond rate | 3.2% | 3.7% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 0.44 | 0.63 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 5.40% | 8.00% |
| Tax rate | 25.90% | 26.50% |
| Debt/Equity ratio | 0 | 0 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 5.4% | 8.0% |
| Selected WACC | 6.7% | |